Gabapentin Enacarbil Post-marketing Clinical Study A Randomized, Double-blind, Placebo-controlled, Parallel-group Study in Subjects With Restless Legs Syndrome.
Phase of Trial: Phase IV
Latest Information Update: 19 Jan 2018
At a glance
- Drugs Gabapentin enacarbil (Primary)
- Indications Restless legs syndrome
- Focus Therapeutic Use
- Sponsors Astellas Pharma
- 13 Apr 2017 Status changed from not yet recruiting to recruiting.
- 22 Feb 2017 New trial record